Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Trends in Research Payments for Age-Related Macular Degeneration From 2015 to 2021 | Synapse

September 1, 2024

Trends in Research Payments for Age-Related Macular Degeneration From 2015 to 2021

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study aimed to evaluate characteristics of industry and public research payments for age-related macular degeneration studies.

Preguntar a la IA

Me gusta

Guardar

Compartir

Cite This Study

Lee et al. (Sun,) studied this question.

synapsesocial.com/papers/68e59fb2b6db64358753a7e1 https://doi.org/https://doi.org/10.3928/23258160-20240903-01

Preguntar a la IA

Me gusta

Guardar

Compartir

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration2020 · 237 citations
2Impact of COVID-19 on clinical trials and clinical research: A systematic review2020 · 242 citations
3End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration2020 · 75 citations
4Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option2021 · 49 citations
5Age-related macular degeneration (AMD): pathogenesis and therapy.2006 · 610 citations